Abiopharma

🔍 Artal Participations S.a r.l. (Executive)

Company: CAVA GROUP, INC. (CAVA)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Sold 3,000,000 shares of Common Stock at $90.3 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: false | shares_owned_after: 6,507,990.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The securities are held directly by Artal Participations S.a r.l. The sole shareholder of Artal Participations S.a r.l. is Artal International S.C.A. The managing partner of Artal International S.C.A. is Artal International Management S.A. The sole stockholder of Artal International Management S.A. is Artal Group S.A. The parent company of Artal Group S.A. is Westend S.A. The majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend (the "Stichting"). Mr. Amaury Wittouck is the sole member of the board of the Stichting.
• F2: (Continued from Footnote 1) Each of the Reporting Persons, other than Artal Participations S.a r.l., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
• REMARKS: For purposes of Section 16 of the Exchange Act, the Reporting Persons may be deemed to be directors by deputization of the Issuer by virtue of their representatives on the Issuer's board of directors.